secwatch.observer — SEC 8-K summary
======================================

Issuer:     HCW Biologics Inc. (HCWB)
CIK:        0001828673
Form:       8-K
Filed at:   2025-07-18T23:59:59+00:00
Accession:  0000950170-25-096950
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01
LLM model:  deepseek-v4-flash:cloud@v2

HCW Biologics extends $7M license fee payment from WY Biotech to Sept 30, 2025
------------------------------------------------------------------------------

- WY Biotech completed due diligence and elected to continue exclusive license agreement with HCW Biologics.
- WY Biotech's obligation includes a $7.0 million upfront license fee, originally due earlier.
- Parties agreed to extend payment deadline; confirmation of wire transfer expected on or before Sept 30, 2025.
- Amendment accommodates WY Biotech's timing for finalizing CDMO and investor agreements.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1828673/000095017025096950/0000950170-25-096950-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1828673/000095017025096950/hcwb-20250714.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-096950

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer